Skip to Navigation | Skip to Main Content | Skip to Site Map

FLHouse.gov | Mobile Site

Senate Tracker: Sign Up | Login

The Florida Senate

SB 816 — Diabetes Research

by Senator Bradley

This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.

Prepared by: Education Postsecondary Committee (HE)

The bill codifies the University of Florida Diabetes Institute (institute) within the University of Florida College of Medicine as a statewide resource for diabetes research, prevention, treatment, and education. The institute’s purpose is to advance scientific discovery, improve prevention and care, and promote education and outreach related to diabetes and related metabolic conditions.

 

The bill requires the institute to conduct research on the causes, mechanisms, and potential cures of diabetes; develop advanced prevention, diagnostic, and treatment strategies; and provide comprehensive, multidisciplinary clinical care for individuals living with diabetes. The institute must also train and educate health care professionals to expand expertise in diabetes care and research.

 

The bill further requires the institute to collaborate with specified groups to advance diabetes research and care, and to engage in community-based outreach and education programs to reduce disparities and promote healthier lifestyles.

 

The bill authorizes the institute to establish and administer statewide pilot programs, including screening and prevention initiatives and technology-driven management tools. The institute must maintain a secure repository of deidentified data to support initiatives and may share such data with research collaborators under data-sharing agreements to support ongoing and future scientific investigations.

 

The bill also authorizes the institute to convene a statewide diabetes research and care consortium to coordinate research, share expertise, and develop innovative care models. The consortium must be administered under the direction of the institute’s executive leadership and may solicit funding from public, nonprofit, and private sources to expand programs, research initiatives, and community services.

 

Beginning October 15, 2027, the institute must submit an annual report to the Governor and Legislature detailing research projects and findings, clinical services provided and patient outcomes, community outreach and prevention initiatives, and recommendations for future initiatives.

 

The bill’s implementation is contingent upon appropriations provided in the General Appropriations Act or from other available funds.

 

If approved by the Governor, or allowed to become law without the Governor's signature, these provisions take effect on July 1, 2026.

 

Vote: Senate 39-0; House 114-0